Summary
This Form 8-K filing from Cencora, Inc. (formerly AmerisourceBergen Corporation) on March 23, 2021, primarily serves to provide investors with crucial financial information regarding the "Alliance Healthcare" businesses of Walgreens Boots Alliance, Inc. (WBA), which the Company agreed to acquire for approximately $6.5 billion. This report includes detailed audited and unaudited financial statements for the Alliance Healthcare business, as well as pro forma combined financial statements that merge the historical financials of both Cencora and the target business. These financial disclosures are critical for investors to assess the financial health and performance of the asset Cencora is acquiring and to understand the potential financial implications of the integration. The acquisition, valued at $6.275 billion in cash and 2 million shares of Cencora common stock, is a significant strategic move aimed at expanding Cencora's global reach and capabilities in pharmaceutical distribution and related services. The filing underscores the importance of the provided financial data for due diligence and understanding the expected financial profile of the combined entity post-acquisition. Investors should carefully review the included financial statements and pro forma information to gauge the accretion or dilution from this transaction and Cencora's future growth prospects.
Key Highlights
- 1Cencora (formerly AmerisourceBergen) is providing key financial information for the "Alliance Healthcare" businesses being acquired from Walgreens Boots Alliance (WBA).
- 2The total transaction value is approximately $6.5 billion, comprising $6.275 billion in cash and 2 million shares of Cencora common stock.
- 3The filing includes audited financial statements for the Alliance Healthcare business for the years ended August 31, 2020, and August 31, 2019.
- 4Unaudited condensed financial statements for the Alliance Healthcare business as of November 30, 2020, and for the three months then ended are also provided.
- 5Pro forma combined financial statements are included, presenting a hypothetical combination of Cencora's and Alliance Healthcare's financials as of December 31, 2020, and for the year ended September 30, 2020.
- 6The filing incorporates by reference the consent of Deloitte & Touche LLP, the independent auditors for the Alliance Healthcare business.
- 7The provided pro forma financial information is for informational purposes only and does not represent the actual results of the combined companies.